Synlogic, Inc. (SYBX)
1.175
0.00 (0.00%)
USD |
OTCM |
Sep 08, 16:00
Synlogic Enterprise Value : 0.5605M for Sept. 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 0.5605M |
| September 04, 2026 | 0.502M |
| September 03, 2026 | 1.087M |
| September 02, 2026 | 1.087M |
| September 01, 2026 | 1.087M |
| August 31, 2026 | 1.087M |
| August 28, 2026 | 1.087M |
| August 27, 2026 | 0.9991M |
| August 26, 2026 | 1.087M |
| August 25, 2026 | 0.9699M |
| August 24, 2026 | 0.619M |
| August 21, 2026 | 0.8529M |
| August 20, 2026 | 1.087M |
| August 19, 2026 | 1.204M |
| August 18, 2026 | 0.8529M |
| August 17, 2026 | 0.8529M |
| August 14, 2026 | 1.087M |
| August 13, 2026 | 1.204M |
| August 12, 2026 | 0.2681M |
| August 11, 2026 | 0.619M |
| August 10, 2026 | 0.9114M |
| August 07, 2026 | 1.204M |
| August 06, 2026 | 0.8529M |
| August 05, 2026 | 0.619M |
| August 04, 2026 | 0.619M |
| Date | Value |
|---|---|
| August 03, 2026 | 0.502M |
| July 31, 2026 | 0.8529M |
| July 30, 2026 | 0.2681M |
| July 29, 2026 | -0.0828M |
| July 28, 2026 | -4.761M |
| July 27, 2026 | -5.349M |
| July 24, 2026 | -5.349M |
| July 23, 2026 | -5.349M |
| July 22, 2026 | -4.867M |
| July 21, 2026 | -4.938M |
| July 20, 2026 | -4.938M |
| July 17, 2026 | -4.609M |
| July 16, 2026 | -4.609M |
| July 15, 2026 | -4.982M |
| July 14, 2026 | -4.867M |
| July 13, 2026 | -4.867M |
| July 10, 2026 | -4.867M |
| July 09, 2026 | -4.829M |
| July 08, 2026 | -4.984M |
| July 07, 2026 | -4.858M |
| July 06, 2026 | -4.984M |
| July 02, 2026 | -4.984M |
| July 01, 2026 | -4.984M |
| June 30, 2026 | -4.984M |
| June 29, 2026 | -5.904M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agenus, Inc. | 581.29M |
| Amgen, Inc. | 255.86B |
| Anika Therapeutics, Inc. | 268.42M |
| BioCryst Pharmaceuticals, Inc. | 2.798B |
| Imunon, Inc. | 8.166M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.543M |
| Total Expenses (Quarterly) | 0.543M |
| EPS Diluted (Quarterly) | -0.0437 |
| Earnings Yield | -3.97% |
| Normalized Earnings Yield | -17.16 |